What is NDC 0054-0825?

0054-0825 is the product NDC for Deflazacort, Deflazacort 18 mg/1 tablet, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0054. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Deflazacort?

31 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Deflazacort NDC 0054-0825 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0054-0825Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00054-0825Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0054-0825-13	0005408251300054082513	30 TABLET in 1 BOTTLE (0054-0825-13)Marketed from Oct 7, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Deflazacort
Generic name (nonproprietary): deflazacort
Active ingredients: Deflazacort — 18 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0054
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 220524
Marketing start: Oct 7, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 0054-0825_b019324e-dbd3-4404-a0b5-021d67c0270bSPL ID b019324e-dbd3-4404-a0b5-021d67c0270b
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400054082513 followed by a unit qualifier and the quantity

Package 00054-0825-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 0054-0825

What is NDC 0054-0825?: 0054-0825 is the product NDC for Deflazacort, Deflazacort 18 mg/1 tablet, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Deflazacort.
What is the active ingredient?: Deflazacort.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0054. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Deflazacort?: 31 other product NDCs are listed under this name. See all Deflazacort NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Deflazacort NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Deflazacort	Deflazacort 6 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0824	00054-0824-25
Deflazacort	Deflazacort 30 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0826	00054-0826-13
Deflazacort	Deflazacort 36 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0827	00054-0827-13
Deflazacort	Deflazacort 6 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2282	60219-2282-01
Deflazacort	Deflazacort 18 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2283	60219-2283-01
Deflazacort	Deflazacort 30 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2284	60219-2284-01
Deflazacort	Deflazacort 36 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2285	60219-2285-01
Deflazacort	Deflazacort 6 mg/1	TabletOral	AvKARE	73190-068	73190-0068-01
Deflazacort	Deflazacort 18 mg/1	TabletOral	AvKARE	73190-069	73190-0069-30
Deflazacort	Deflazacort 30 mg/1	TabletOral	AvKARE	73190-070	73190-0070-30

All 32 Deflazacort NDCs

Other NDCs under ANDA 220524

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 220524
Product	Strength	Form · route	Labeler	Product NDC
Deflazacort	Deflazacort 6 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0824
Deflazacort	Deflazacort 30 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0826
Deflazacort	Deflazacort 36 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0827